関連する実験動画
Updated: Dec 11, 2025

07:33
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
35.6K
大規模なトポロジック変化が結腸癌の悪性進行を抑制する
Sarah E Johnstone1, Alejandro Reyes2, Yifeng Qi3
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02129, USA.
Cell
|August 26, 2020
まとめ
癌はゲノム構造を変えて オープンとクローズドの 空間的分割を損ねます これらのトポロジカルな変化は,抗腫瘍免疫を誘発しながら,幹と侵入を抑制することによって,腫瘍の成長を抑制する可能性があります.
科学分野:
- ゲノミクス
- 癌 生物学
- エピジェネティクス
背景:
- 癌は広範囲にわたるDNAメチル化とクロマチンの変化と関連しています.
- これらの変化が上位階の染色体構造に与える影響は十分に理解されていません.
研究 の 目的:
- クロマチンループ,トポロジカルに関連したドメイン,大腸腫瘍における大規模なゲノムコンパートメントの変異を特徴付ける.
- 癌の進行におけるこれらのトポロジ的変化の機能的影響を調査する.
主な方法:
- 結腸腫瘍と正常結腸のトポロジカルマップの統合
- エピジェネティック,トランスクリプション,画像データの分析.
- 悪性細胞と非悪性細胞におけるゲノム組織の比較
主要な成果:
- 腫瘍では開いたゲノムと閉じたゲノムを空間的に分ける事が有意に妨げられます.
- 腫瘍に関連するトポロジカルな変化には,コンパートメント特有の低メチル化およびクロマチンの変化が含まれます.
- A/Bコンパートメントのインターフェイスで新しいコンパートメントが再編成され,過剰な分裂を持つ非悪性細胞で同様のシフトが観察されます.
結論:
- 腫瘍に関連したトポロジカルゲノム変異は,茎性および侵入プログラムを抑制する可能性があります.
- これらの変化は抗腫瘍免疫遺伝子を誘発し,悪性腫瘍の進行を抑制する可能性があります.
- この発見は,がんにおける表遺伝子学的変化が 腫瘍性だけであるという見解に異議を唱える.
関連する概念動画
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K

